There are presently simply no effective therapies for fibrodysplasia ossificans progressiva (FOP) a debilitating and progressive heterotopic ossification disease due to activating mutations of ACVR1 encoding the BMP type I receptor kinase ALK2. with selectivity or strength suggesting systems independent of BMP or TGF-β inhibition. The analysis also shows a powerful 2 derivative 10 (LDN-214117)… Continue reading There are presently simply no effective therapies for fibrodysplasia ossificans progressiva